A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants
Clinical trial NCT03341884 · COMPLETED
Trial details
- NCT number
- NCT03341884
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2018-06-26
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.